References
- American Cancer Society. Key statistics for colorectal cancer. 2018 Available from: https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html. Accessed January 24, 2018.
- National Cancer Institute. SEER cancer stat facts: colorectal cancer. Available from: http://seer.cancer.gov/statfacts/html/colorect.html. Accessed January 10, 2018.
- Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology. 1987;93(5):1009–1013.3653628
- Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am. 2002;12(1):1–9, v.11916153
- American Cancer Society. Colorectal cancer facts & figures 2017–2019. 2017 Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf. Accessed August 23, 2017.
- Centers for Medicare and Medicaid Services. Consensus core set: gastroenterology measures version 1.0. 2015 Available from: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/Downloads/Gastroenterology-Measures.pdf. Accessed January 31, 2018.
- Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101(4):873–885.16635231
- Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut. 2007;56(11):1585.17591622
- Ahn SB, Han DS, Bae JH, Byun TJ, Kim JP, Eun CS. The miss rate for colorectal adenoma determined by quality-adjusted, back-to-back colonoscopies. Gut Liver. 2012;6(1):64–70.22375173
- Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112(1):24–28.8978338
- Lee TJ, Rees CJ, Blanks RG, et al. Colonoscopic factors associated with adenoma detection in a national colorectal cancer screening program. Endoscopy. 2014;46(3):203–211. doi:10.1055/s-0033-135883124473907
- Patel N, Darzi A, Teare J. The endoscopy evolution: ‘the superscope era‘. Frontline Gastroenterol. 2015;6(2):101–107. doi:10.1136/flgastro-2014-10044825878767
- ASGE Technology Committee, Konda V, Chauhan SS, et al. Endoscopes and devices to improve colon polyp detection. Gastrointest Endosc. 2015;81(5):1122–1129. doi:10.1016/j.gie.2014.10.00625746978
- Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370(14):1298–1306. doi:10.1056/NEJMoa130908624693890
- Chin M, Karnes W, Jamal MM, et al. Use of the Endocuff® during routine colonoscopy examination improves adenoma detection: ameta-analysis. World J Gastroenterol. 2016;22(43):9642–9649. doi:10.3748/wjg.v22.i43.964227920485
- Patil R, Ona MA, Ofori E, Reddy M. Endocuff®-assisted colonoscopy-A novel accessory in improving adenoma detection rate: a review of the literature. Clin Endosc. 2016;49(6):533–538. doi:10.5946/ce.2016.03227133962
- Facciorusso A, Del Prete V, Buccino RV, et al. Comparative efficacy of colonoscope distal attachment devices in increasing rates of adenoma detection: a network meta-analysis. Clin Gastroenterol Hepatol. 2017; 16(8):1209–1219.
- Ramsey S, Willke R, Briggs A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health. 2005;8(5):521–533. doi:10.1111/j.1524-4733.2005.00045.x16176491
- Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices–overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–1. Value Health. 2012;15(6):796–803. doi:10.1016/j.jval.2012.06.01222999128
- Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–7. Value Health. 2012;15(6):843–850.22999134
- Roberts M, Russell LB, Paltiel AD, Chambers M, McEwan P, Krahn M. Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–2. Value Health. 2012;15(6):804–811. doi:10.1016/j.jval.2012.06.01622999129
- Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–3. Value Health. 2012;15(6):812–820. doi:10.1016/j.jval.2012.06.01422999130
- National Comprehensive Cancer Network®. NCCN clinical practice guidelines in oncology (NCCN guidelines) colorectal cancer screening version 1.2017. 2017 Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed July 24, 2017.
- Centers for Medicare and Medicaid Services. Physician/supplier procedure summary master file. 2016 Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Files-for-Order/NonIdentifiableDataFiles/PhysicianSupplierProcedureSummaryMasterFile.html. Accessed November 7, 2017.
- Biecker E, Floer M, Heinecke A, et al. Novel endocuff®-assisted colonoscopy significantly increases the polyp detection rate: a randomized controlled trial. J Clin Gastroenterol. 2015;49(5):413–418. doi:10.1097/MCG.000000000000016624921209
- Floer M, Biecker E, Fitzlaff R, et al. Higher adenoma detection rates with endocuff®-assisted colonoscopy – a randomized controlled multicenter trial. PLoS One. 2014;9(12):e114267. doi:10.1371/journal.pone.011426725470133
- Lenze F, Beyna T, Lenz P, Heinzow HS, Hengst K, Ullerich H. Endocuff®-assisted colonoscopy: a new accessory to improve adenoma detection rate? Technical aspects and first clinical experiences. Endoscopy. 2014;46(7):610–614. doi:10.1055/s-0034-136544624824090
- Sawatzki M, Meyenberger C, Marbet UA, Haarer J, Frei R. Prospective Swiss pilot study of Endocuff®-assisted colonoscopy in a screening population. Endosc Int Open. 2015;3(3):E236–239. doi:10.1055/s-0034-139141826171436
- Marsano J, Tzimas D, Razavi F, et al. Endocuff® assisted colonoscopy increases adenoma detection rates: a multi-center study. Gastrointest Endosc. 2014;79(5 Suppl):AB550. doi:10.1016/j.gie.2014.02.911
- National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: incidence – SEER 9 Regs Research Data, Nov 2016 Sub (1973-2014) <Katrina/Rita Population Adjustment> – Linked To County Attributes – Total U.S., 1969-2015 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2017, based on the November 2016 submission. Available from: www.seer.cancer.gov. Accessed September 25, 2017.
- Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection–systematic review and meta-analysis. Radiology. 2011;259(2):393–405. doi:10.1148/radiol.1110188721415247
- Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Decreased risk of colorectal cancer after colonoscopy in patients 76–85 years old in the United States. Digestion. 2016;93(2):132–138. doi:10.1159/00044257126636320
- Cooper GS, Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004;100(2):418–424. doi:10.1002/cncr.2001414716780
- Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME. Relation between medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006;296(23):2815–2822. doi:10.1001/jama.296.23.281517179458
- Teloken PE, Ransom D, Faragher I, Jones I, Gibbs P, Platell C. Recurrence in patients with stage I colorectal cancer. ANZ J Surg. 2015; 86(1-2):49–53.
- Allegra CJ, Yothers G, O‘Connell MJ, et al. Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial. J Clin Oncol. 2013;31(3):359–364. doi:10.1200/JCO.2012.44.471123233715
- Centers for Disease Control and Prevention. National vital statistics report: United States life tables, 2014. 2017 Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr66/nvsr66_04.pdf. Accessed August 22, 2017.
- Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care. 2005;43(11):1078–1086.16224300
- Ness RM, Holmes AM, Klein R, Dittus R. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol. 1999;94(6):1650–1657. doi:10.1111/j.1572-0241.1999.01157.x10364039
- Ramsey SD, Andersen MR, Etzioni R, et al. Quality of life in survivors of colorectal carcinoma. Cancer. 2000;88(6):1294–1303.10717609
- Centers for Medicare and Medicaid Services. Physician fee schedule. 2017 Available from: https://www.cms.gov/apps/physician-fee-schedule/. Accessed August 24, 2017.
- Centers for Medicare and Medicaid Services. Ambulatory Surgical Center (ASC) payment – July 2017 ASC approved HCPCS code and payment rates. 2017 Avaialble from: https://www.cms.gov/medicare/medicare-fee-for-service-payment/ascpayment/11_addenda_updates.html. Accessed August 24, 2017.
- Centers for Medicare and Medicaid Services. Hospital outpatient PPS – July 2017 addendum B update. 2017 https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalOutpatientPPS/Addendum-A-and-Addendum-B-Updates-Items/2017-July-Addendum-B.html. Accessed August 24, 2017.
- Leffler DA, Kheraj R, Garud S, et al. The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy. Arch Intern Med. 2010;170(19):1752–1757. doi:10.1001/archinternmed.2010.37320975024
- Centers for Medicare and Medicaid Services. Health expenditures by state of residence, 1991–2014. 2017 Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NationalHealthAccountsStateHealthAccountsResidence.html. Accessed August 28, 2017.
- Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst. 2009;101(20):1412–1422. doi:10.1093/jnci/djp31919779203
- Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-utility analysis of chemotherapy regimens in elderly patients with stage III colon cancer. Pharmaco Econ. 2014;32(10):1005–1013. doi:10.1007/s40273-014-0180-8
- Song X, Zhao Z, Barber B, Gregory C, Schutt D, Gao S. Characterizing medical care by disease phase in metastatic colorectal cancer. J Oncol Pract. 2011;7(3 Suppl):25s–30s.21886516
- Siu AL; Force USPST. Screening for breast cancer: U.S. Preventive Services task force recommendation statement. Ann Intern Med. 2016;164(4):279–296.26757170
- Rex DK, Repici A, Gross SA, et al. High-definition colonoscopy versus Endocuff® versus EndoRings versus full-spectrum endoscopy for adenoma detection at colonoscopy: a multicenter randomized trial. Gastrointest Endosc. 2018;88(2):335–344.e332.29530353